Related Experiment Video
Updated: Feb 12, 2026

Orthotopic Liver Transplantation in Rats
Published on: July 1, 2012
Systemic inflammatory response in a liver transplant recipient: a potential side effect of mycophenolate mofetil
Rebecca Smith1, Adam Testro1,2
1Liver Transplant Unit Victoria, Austin Health, Australia.
Abstract:
Mycophenolate mofetil is a commonly used immunosuppressive medication in the postliver transplant setting where gastrointestinal side effects tend to predominate. However, in more recent times, emerging and rare side effects are being reported in the literature. We present a case of a patient who had a significant inflammatory response and associated marked weight loss with the uptitration in dose of mycophenolate mofetil. Extensive investigations were performed to exclude other infective, inflammatory or malignant aetiologies for these symptoms, however no other cause was identified. The patient had the medication ceased and subsequently had a dramatic improvement in his inflammatory markers and regained the weight lost while on the medication.
Insights
Mycophenolate mofetil can cause rare inflammatory responses and weight loss in liver transplant patients. Stopping the medication led to significant recovery, highlighting a potential adverse effect.
Area of Science:
- Immunology
- Pharmacology
- Gastroenterology
Background:
- Mycophenolate mofetil is a key immunosuppressant post-liver transplant.
- Gastrointestinal side effects are common, but rare adverse events are emerging.
- Monitoring for atypical drug toxicity is crucial in transplant recipients.
Observation:
- A liver transplant patient developed severe inflammation and weight loss.
- Symptoms correlated with dose escalation of mycophenolate mofetil.
- Exhaustive investigations ruled out infection, malignancy, and other inflammatory causes.
Findings:
- Cessation of mycophenolate mofetil resulted in rapid improvement of inflammatory markers.
- The patient experienced significant weight regain after discontinuing the medication.
- This suggests a direct link between mycophenolate mofetil and the observed inflammatory response.
Implications:
- Highlights a rare, severe adverse effect of mycophenolate mofetil.
- Suggests the need for heightened awareness and monitoring for inflammatory syndromes.
- Informs clinical practice regarding the management of potential drug-induced toxicity in transplant patients.
More Related Videos
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Inflammatory Response I: Vascular and Cellular
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Second Order systems II
Standard Electrode Potentials

